Latest filing published 17 Jul 2025 for NewAmsterdam Pharma Co N.V., €447k.
Insider track record
Douglas F. Kling: trading record in brief
All filings by Douglas F. Kling on record concern NewAmsterdam Pharma Co N.V. Over a trading history stretching from 7 January 2025 to 16 July 2025, the count stands at 35 filings.
On the market, this insider has only sold: 19 sales, €3.5M in total. The totals exclude 14 filings filed without an amount. Other entries cover 1 share grant and 15 option exercises.
The record was last updated on 17 July 2025 with an open-market sale (€811k) in NewAmsterdam Pharma Co N.V. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Douglas F. Kling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 47,569 shares@ US$10.9015.4% of flowOrdinary SharesSEC:0000950170-25-096665:0
- 78,101 shares@ US$10.0023.3% of flowOrdinary SharesSEC:0000950170-25-087937:0
- 100,000 shares@ US$10.0030.8% of flowOrdinary SharesSEC:0000950170-25-074463:0
- 100,000 shares@ US$10.0030.5% of flowOrdinary SharesSEC:0000950170-25-055612:0
- 16,539 shares0Ordinary SharesSEC:0000950170-25-046943:0
- 88,112 sharesOrdinary SharesSEC:0000950170-25-042176:0
- 90,782 sharesOrdinary SharesSEC:0000950170-25-024322:0
- 56,863 sharesOrdinary SharesSEC:0000950170-25-011854:0
- 104,174 sharesOrdinary SharesSEC:0000950170-25-010575:0
- 44,000 sharesOrdinary SharesSEC:0000950170-25-002979:0
10 of 10 declarations
